Estrogen receptor β1 and the β2/βcx isoforms in nonneoplastic endometrium and in endometrioid carcinoma

International Journal of Gynecological Cancer

Volumn 17, Issue 4, 2007, Pages 905-913

  Chakravarty, D ^a   Srinivasan, R ^a   Ghosh, S ^a   Gopalan, S ^a   Rajwanshi, A ^a   Majumdar, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Beta cx; Carcinoma; Endometrioid; Endometrium; Estrogen receptor beta 1; Estrogen receptor beta 2

Indexed keywords

ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR; ISOPROTEIN; MESSENGER RNA;

ANTIBODY DETECTION; ARTICLE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOSYNTHESIS; CANCER STAGING; DISEASE COURSE; ENDOMETRIUM TUMOR; FEMALE; GENETICS; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY;

CARCINOMA, ENDOMETRIOID; DISEASE PROGRESSION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PROTEIN ISOFORMS; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 34447345990     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00851.x     Document Type: Article

References (21)

1. Enmark E, Pelto-Huikko M, Grandien K et al. Human estrogen receptor β-gene structure, chromosomal localisation and expression pattern. J Clin Endocrinol Metab 1997 82: 4258 65.
2. Moore JT, McKee DD, Slentz-Kesler K et al. Cloning and characterization of human estrogen receptor beta isoforms. Biochem Biophys Res Commun 1998 247: 75 8.
3. Ogawa S, Inoue S, Watanabe T et al. Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human. Nucleic Acids Res 1998 26: 3505 12.
4. Danielian PS, White R, Lees JA, Parker MG. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J 1992 11: 1025 33.
5. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 1994 13: 5370 82.
6. Le Douarin B, Zechel C, Garnier JM et al. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 1995 14: 2020 33.
7. Saji S, Omoto Y, Shimizu C et al. Expression of estrogen receptor (ER) (beta) cx protein in ER (alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res 2002 62: 4849 53.
8. Skrzypczak M, Bieche I, Szymczak S et al. Evaluation of mRNA expression of estrogen receptor beta and its isoforms in human normal and neoplastic endometrium. Int J Cancer 2004 110: 783 7.
9. Critchley HO, Henderson TA, Kelly RW et al. Wild-type estrogen receptor (ER beta1) and the splice variant (ER betacx/beta2) are both expressed within the human endometrium throughout the normal menstrual cycle. J Clin Endocrinol Metab 2002 87: 5265 73.
10. Rajkumar T, Gullick WJ. The production of antibodies using synthetic peptides as immunogens. In: Jankowski JA, Polak JM, eds. Clinical gene analysis and manipulation. Melbourne, Australia: Cambridge University Press, 1996: 99 110.
11. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979 76: 4350 4.
12. Harvey JM, Clark GM, Osborne CK, Allred DC. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999 17: 1474 81.
13. Palmieri C, Cheng GJ, Saji S et al. Estrogen receptor beta in breast cancer. Endocr Relat Cancer 2002 9: 1 13.
14. Palmieri C, Saji S, Sakaguchi et al 2004) The expression of oestrogen receptor (ER) beta and its variants, but not ER alpha in adult human mammary fibroblasts. J Mol Endocrinol 33: 35 50.
15. Saji S, Omoto Y, Shimizu C et al. Clinical impact of assay of estrogen receptor beta cx in breast cancer. Breast Cancer 2002 9: 303 7.
16. Krikun G, Schatz F, Taylor R et al. Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression. J Clin Endocrinol Metab 2005 90: 1812 8.
17. Lecce G, Meduri G, Ancelin M, Bergeron C, Perrot-Applanat M. Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells. J Clin Endocrinol Metab 2001 86: 1379 86.
18. Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ. Histologic typing of female genital tract tumours (international histological classification of tumours), 2nd edn. New York: Springer-Verlag, 1994: 1 189.
19. Kurman RJ, Kaminski PF, Norris HJ. The behaviour of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 1985 56: 403 12.
20. Bardin A, Boulle N, Lazennec G, Vignon F, Pujol P. Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr Relat Cancer 2004 11: 537 51.
21. Weihua Z, Saji S, Makinen S et al. Estrogen Receptor (ER) beta, a modulator of ER alpha in the uterus. Proc Natl Acad Sci USA 2000 97: 5936 41.